PH13030A - Cephalosporin derivative and pharmaceutical preparation thereof - Google Patents

Cephalosporin derivative and pharmaceutical preparation thereof

Info

Publication number
PH13030A
PH13030A PH17273A PH17273A PH13030A PH 13030 A PH13030 A PH 13030A PH 17273 A PH17273 A PH 17273A PH 17273 A PH17273 A PH 17273A PH 13030 A PH13030 A PH 13030A
Authority
PH
Philippines
Prior art keywords
pharmaceutical preparation
cephalosporin derivative
cephalosporin
derivative
pharmaceutical
Prior art date
Application number
PH17273A
Other languages
English (en)
Inventor
M Montavon
R Reiner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH13030A publication Critical patent/PH13030A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH17273A 1974-06-21 1975-06-17 Cephalosporin derivative and pharmaceutical preparation thereof PH13030A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives

Publications (1)

Publication Number Publication Date
PH13030A true PH13030A (en) 1979-11-15

Family

ID=4341690

Family Applications (1)

Application Number Title Priority Date Filing Date
PH17273A PH13030A (en) 1974-06-21 1975-06-17 Cephalosporin derivative and pharmaceutical preparation thereof

Country Status (25)

Country Link
JP (1) JPS625917B2 (nl)
AT (1) AT337897B (nl)
AU (1) AU498387B2 (nl)
BE (1) BE830455A (nl)
BR (1) BR7503782A (nl)
CA (1) CA1111021A (nl)
CH (1) CH609989A5 (nl)
CU (1) CU34293A (nl)
DD (1) DD121113A5 (nl)
DE (1) DE2527291A1 (nl)
DK (2) DK153155C (nl)
FI (1) FI751815A (nl)
FR (1) FR2275215A1 (nl)
GB (1) GB1471804A (nl)
HU (1) HU170576B (nl)
IE (1) IE41888B1 (nl)
IL (1) IL47299A (nl)
LU (1) LU72771A1 (nl)
NL (1) NL180665C (nl)
NO (1) NO752202L (nl)
NZ (1) NZ177508A (nl)
PH (1) PH13030A (nl)
SE (1) SE431755B (nl)
SU (2) SU635873A3 (nl)
ZA (1) ZA753086B (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1599232A (en) * 1977-06-03 1981-09-30 Hoffmann La Roche 7-(2-oximinoacetamido)-cephalosporin derivatives
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
CN1531598A (zh) * 2001-04-19 2004-09-22 ��ŷ�����¶����ǹɷ����޹�˾ 制备头孢菌素衍生物的酶促方法
EP2250156B1 (en) * 2008-03-05 2015-05-06 Merck Patent GmbH Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Also Published As

Publication number Publication date
JPS5113793A (nl) 1976-02-03
SE431755B (sv) 1984-02-27
AU8191275A (en) 1976-12-09
FI751815A (nl) 1975-12-22
SU635873A3 (ru) 1978-11-30
NL180665C (nl) 1987-04-01
ATA476975A (de) 1976-11-15
CU34293A (es) 1979-01-16
DK453687A (da) 1987-08-28
IE41888L (en) 1975-12-21
DE2527291A1 (de) 1976-01-08
NL180665B (nl) 1986-11-03
IL47299A0 (en) 1976-10-31
AU498387B2 (en) 1979-03-08
ZA753086B (en) 1976-04-28
LU72771A1 (nl) 1977-03-04
NZ177508A (en) 1978-04-03
CH609989A5 (en) 1979-03-30
BR7503782A (pt) 1976-07-06
DK155329C (da) 1989-08-07
DK153155B (da) 1988-06-20
GB1471804A (en) 1977-04-27
AT337897B (de) 1977-07-25
CA1111021A (en) 1981-10-20
SU589921A3 (ru) 1978-01-25
IE41888B1 (en) 1980-04-23
DK153155C (da) 1988-10-31
DK271975A (da) 1975-12-22
BE830455A (fr) 1975-12-22
HU170576B (nl) 1977-07-28
DK155329B (da) 1989-03-28
DE2527291C2 (nl) 1988-01-14
JPS625917B2 (nl) 1987-02-07
FR2275215A1 (fr) 1976-01-16
IL47299A (en) 1979-01-31
NO752202L (nl) 1975-12-23
FR2275215B1 (nl) 1980-05-16
DK453687D0 (da) 1987-08-28
DD121113A5 (nl) 1976-07-12
NL7507390A (nl) 1975-12-23
SE7506908L (sv) 1975-12-22

Similar Documents

Publication Publication Date Title
NZ179495A (en) 1-substituted-4-benzylpiperidines and pharmaceutical compositions
PH10519A (en) 4-hydroxymethyl-1-phthalazone derivatives and pharmaceutical compositions thereof
GB1520447A (en) Benzisoquinoline derivatives and pharmaceutical uses thereof
ZA751102B (en) Pharmaceutical preparations
IL48020A0 (en) Novel cephalosporin derivatives and their preparation
GB1483416A (en) Cephalosporin derivative and its preparation
ZA756481B (en) 4-methylthio-2-trifluoromethyl methane-sulfonanilide and derivatives thereof
PH13030A (en) Cephalosporin derivative and pharmaceutical preparation thereof
PH10643A (en) Benzylpyrimidine derivatives and pharmaceutical compositions thereof
NZ179598A (en) Cephalosporins and pharmaceutical compositions
IL47335A0 (en) Hexahydro-diazepino-indole derivatives and the preparation thereof
GB1533491A (en) Cephalosporin derivatives and the preparation thereof
PH11219A (en) N-substituted-dihydroxyphenethylamine derivatives and pharmaceutical composition thereof
AU8487175A (en) Pharmaceutical preparations
PH10795A (en) D-glucose-1-onicotinoyl-2-deoxy-2-nictinkmido derivatives and pharmaceutical composition thereof
PH11045A (en) Thieno-pyridine derivatives and therapeutic composition thereof
GB1488068A (en) 7alpha-alkoxy-cephalosporin derivatives and their preparation
IL46635A0 (en) New cephalosporin esters and their preparation
ZA746519B (en) Penam derivatives and preparation thereof
ZA747446B (en) Pharmaceutical preparations
ZM16174A1 (en) Cepham derivatives and preparation thereof
NZ178962A (en) 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions
PH12433A (en) Benzodiazepine derivatives and pharmaceutical composition
ZA755515B (en) Pharmaceutical formulations
IE40816B1 (en) Penam derivatives and preparation thereof